Author: Alan Condon

Here are six orthopedic surgeons making headlines this week:

The FDA approved Centinel Spine's prodisc L lumbar total disc replacement device for two-level indications on April 14.

Biotechnology company Vomaris plans to expedite the approval of its bioelectric V.Dox system after research has indicated that viruses are killed upon exposure to the technology, the Daily Independent reports.

Melissa Erickson, MD, is a spine surgeon with Duke University Medical Center in Durham, N.C.

The widespread suspension of elective surgeries due to the COVID-19 pandemic is causing significant economic difficulties for device companies and practices in the orthopedic industry.

Clearwater-based Florida Spine Institute and its surgery center is laying off 62 employees and suspending operations due to mounting economic difficulties caused by the COVID-19 pandemic, Tampa Bay Business Journal reports.  

Leawood, Kan.-based ValueHealth, a privately-held digital healthcare partner, named Scott Martin southwest regional president on April 14.

The FDA on April 14 granted TDi 510(k) clearance for its SonoVision ultrasound system for spine surgery.

Biotechnology company CytoDyn told investors on April 13 that five patients with mild-to-moderate COVID-19 symptoms were able to get off oxygen after taking its leronlimab drug, Proactive Investors reports.

Orthopedic device company Corin USA recently surpassed 25,000 implants with its OMNIBotics system for total knee replacement.